Â鶹ӳ»­

Session III: Effector Cell Redirection Therapy

1:45¨C3:30 p.m.
Maryland Ballroom AB

Talk: The Role of CAR NK and NK Cell Engagers in Cancer Immunotherapy
Presenter:

Talk: Bispecific T Cell Engagers
Presenter:

Session 102: Keynote Address

8:20¨C9:10 a.m.
Potomac Ballroom

Keynote: Targeting the Microbiome to Promote Health and End Cancer
Presenter:

Concurrent Session 105a: Rapid Oral Abstract Session - Basic

12:30¨C1:30 p.m.
Maryland Ballroom A

Abstract 709: A novel mouse model to investigate the impact of B cell-driven immunity in immunotherapy-treated non-small cell lung cancer
Presenter: Alessandra Vaccaro, Ph.D.

Concurrent Session 105b: Rapid Oral Abstract Session - Clinical

12:30¨C1:30 p.m.
Maryland Ballroom CD

Co-chair: Adam Grippin, M.D., Ph.D.

Concurrent Session 106c: Immunoprevention, Immune Interception 

1:45¨C3:25 p.m.
Maryland Ballroom CD

Co-chair:

Talk: Reprogramming the Immune Microenvironment to Intercept Lung Adenocarcinoma Precancer
Presenter:

Concurrent Session 107b: Modulation of Anti-Tumor Immunity by Nerves and Neurotransmitters

3:55¨C5:35 p.m.
Maryland Ballroom AB

Talk: Clinical Perspective of Neuroimmunology?
Presenter:

Session 203: Imaging, Radiomics, and Integrated Biomarkers in IO

9:25¨C11:15 a.m.
Potomac Ballroom

Talk: Future Usage of Radiomics in IO: From Phase I Neoadjuvant to Clinically Advanced Disease
Presenter:

Concurrent Session 207d: Oral Abstract Session 

3:30¨C5:10 p.m.
National Harbor 2-3

Abstract 419: SARS-CoV-2 mRNA vaccines sensitize immunologically ¡°cold¡± tumors to immune checkpoint blockade
Presenter: Adam Grippin, M.D., Ph.D.

Abstract 1228: Immune escape through oncogene-mediated editing of the HLA-ligandome
Presenter:

Session 301: Presidential Session

8:05-9:30 a.m.
Potomac Ballroom

Abstract 676: Lymphatic-sparing immunoradiotherapy reprograms migratory dendritic cells to drive tumor rejection via the sentinel lymph node
Presenter: Robert Saddawi-Konefka, M.D., Ph.D.